Unfortunately, it is not possible to statistically compare the metastatic activity of A375-R2 cells transfected with MARCKS shRNA with that of BRAFi-sensitive A375 melanoma cells in the present study (Figure 6B–D). This evidence concerns the gene MARCKS and melanoma.